T-Cell Lymphoma

Type: Keyphrase
Name: T-Cell Lymphoma
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Elk River teen siblings share cancer stories

Abby Dwyer, who was featured at this year’s Pine Tree Apple Tennis Classic, is a wonderful young adult who faced cancer head-on after being diagnosed with Philadelphia chromosome positive ALL leukemia almost five years ago.Abby has been off treatment ... [Published Minneapolis Star Tribune - Sep 18 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Mundipharma Starts Japan Phase II Trial With Lymphoma Drug

Article # 28140907007Posted: Sep. 9, 2014 2:00 AM GMTExecutive SummaryMundipharma Japan has begun Phase II trial with pralatrexate injection for the treatment of relapsed or refractory peripheral T-cell lymphoma. ... [Published Health News Daily - Sep 09 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Girl Survives Rare Cancer and Raises Awareness for Research

DES MOINES, Iowa –September is dedicated to raising awareness for childhood cancer. Metro families affected by the pediatric disease are doing their part to let people know how cancer affects kids and those who love them.First Grader Lilly Winterbottom ... [Published WHO-TV - Sep 08 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma

Histone deacetylase inhibitor romidepsin has demonstrated durable clinical responses and tolerability in patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma (PTCL, CTCL). Selection of novel drug therapies for patients with relapsed/refractory ... [Published 7thSpace - Sep 08 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Spectrum CEO: Fusilev Sales Healthy, 'Blockbuster' Announcement Soon

Sales of Spectrum's drug Fusilev for patients with metastatic colorectal cancer remain strong heading into the remainder of 2014, said the company's CEO Rajesh Shrotriya. Total revenue was $46.9 million in Spectrum's second quarter, up 41% from the prior ... [Published TheStreet.com - Sep 02 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Cutaneous Intravascular Natural Killer-Cell Lymphoma

A Case Report and Review of the LiteratureYanli Liu, MD, Wen Zhang, MD, Jie An, MD, Hui Li, MD, Shuang Liu, MD, PhDDisclosuresAm J Clin Pathol. 2014;142(2):243-247.Abstract and Introduction AbstractObjectives: To our knowledge, since 2003, there ... [Published General Medicine eJournal - Sep 02 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Anti-cancer drug with active ingredient invented in Latvia approved in U.S.

At the beginning of July 2014, the United States Food and Drug Administration authorized the use of a new anti-cancer drug in medicine, the active ingredient of which was invented and synthesized in Latvia, the head of the Latvian Institute of Organic ... [Published The Baltic Course - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

9-aminonoscapine and its use in treating cancers, including drug-resistant cancers

9-aminonoscapine, prodrugs thereof, and pharmaceutically acceptable salts thereof, are disclosed. Pharmaceutical compositions including 9-aminonoscapine, and methods of preparation and use thereof are disclosed. 9-aminonoscapine is a noscapine analog ... [Published Free Patents Online - Aug 26 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Cancer Therapy Advisor announces Publishers Alliance

ByG.P. Collins, D. Bruce, and T.A. EyreBiomarker-driven chemotherapeutics is becoming a critical part of the state-of-the-art treatment in early- and late-phase clinical trials involving patients with T-cell lymphoma. ... [Published Chemotherapy Advisor - Aug 22 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Antioch grad returning to normal after cancer fight

Antioch, TN (WSMV) -For the last year and a half, Antioch High School graduate Makayla Claussen has been fighting a rare illness.When Channel 4 last caught up with Claussen, she was getting ready for Christmas with her family and beginning to feel more ... [Published WSMV - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

New Therapies in T-cell Lymphoma

ABSTRACT: T-cell lymphomas represent 10–12% of all patients with non-Hodgkin lymphoma (NHL) in the Western world. When cutaneous T-cell lymphoma (CTCL) is excluded, peripheral T-cell lymphoma—not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma ... [Published Chemotherapy Advisor - Aug 21 2014]
First reported Jul 03 2014 - Updated Jul 04 2014 - 5 reports

BioAlliance's lymphoma drug Beleodaq gets accelerated approval from FDA

France-based BioAlliance Pharma has received topotarget accelerated approval from the US Food and Drug Administration (FDA) for Beleodaq to treat patients with relapsed or refractory peripheral T-cell lymphoma (R/R PTCL). ... [Published PBR - News - Jul 04 2014]

Quotes

Such advances can extend life, but the initial cost is very expensive. But it's been shown that "people are wiling to spend $50,000 to $100,000 or more for another year of life" McClellan said
"I didn't feel anything when they put it in," Moore said. "No pain at all. I went home the next day with no restrictions. Now I can drive. I even trimmed the hedge."
"My brother wasn't a match, so they went to bone marrow registry and they found a lady from Germany who was a match" Claussen said. "She saved my life."

More Content

All (55) | News (47) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Elk River teen siblings share cancer stories [Published Minneapolis Star Tribune - Sep 18 2014]
Eminem Publishers Sue N.Z. Party: Intellectual ... [Published Bloomberg - Sep 17 2014]
Takeda Pharmaceutical to headquarter global onc... [Published Boston Globe - Sep 16 2014]
AbbVie Is Betting Big On Infinity Pharmaceutica... [Published Seeking Alpha - Sep 09 2014]
A Doggy Birthday Party, Celebrities, and the CL... [Published Examiner.com - Sep 09 2014]
Mundipharma Starts Japan Phase II Trial With Ly... [Published Health News Daily - Sep 09 2014]
Girl Survives Rare Cancer and Raises Awareness ... [Published WHO-TV - Sep 08 2014]
600 at symposium seek continued transformation ... [Published Insurance News Net - Sep 08 2014]
VIDEO AND GALLERY: Hundreds take to the saddle ... [Published Bournemouth Daily Echo - Sep 08 2014]
Tolerability to romidepsin in patients with rel... [Published 7thSpace - Sep 08 2014]
Clinical trial tests tiny experimental pacemake... [Published Health Canal - Sep 05 2014]
When Pets Complete Chemotherapy Are They Cancer... [Published Examiner.com - Sep 03 2014]
Risk factors identified for certain lymphoma su... [Published National Cancer Institute - Sep 03 2014]
For Sara Anderson, life goes on, without cancer [Published SalemNewsonline.com - Sep 03 2014]
Spectrum CEO: Fusilev Sales Healthy, 'Blockbust... [Published TheStreet.com - Sep 02 2014]
Cutaneous Intravascular Natural Killer-Cell Lym... [Published General Medicine eJournal - Sep 02 2014]
Onxeo Strengthens Beleodaq® Patent Protection i... [Published Market Pulse Navigator - Aug 28 2014]
Spectrum Pharmaceuticals: A Long-Term Bet [Published Seeking Alpha - Aug 28 2014]
Shift of HIV Tropism in Stem-Cell Transplantati... [Published New England Journal of Medicine - Aug 28 2014]
Anti-cancer drug with active ingredient invente... [Published The Baltic Course - Aug 26 2014]
9-aminonoscapine and its use in treating cancer... [Published Free Patents Online - Aug 26 2014]
Cancer Therapy Advisor announces Publishers All... [Published Chemotherapy Advisor - Aug 22 2014]
Antioch grad returning to normal after cancer f... [Published WSMV - Aug 21 2014]
New Therapies in T-cell Lymphoma [Published Chemotherapy Advisor - Aug 21 2014]
Pageant contestant not centered on beauty [Published Observer News - Aug 15 2014]
New pathology software improves cancer diagnosis [Published MTB Europe - Aug 15 2014]
Leukemia & Lymphoma Society seeks contributors ... [Published Mississippi Press - Aug 13 2014]
Canine Cancer: Lymphoma [Published DogChannel.com - Aug 13 2014]
Aratana Therapeutics' (PETX) CEO Steven St. Pet... [Published Seeking Alpha - Aug 12 2014]
Spectrum Pharmaceuticals (SPPI) Posts Strong Ea... [Published Zacks.com - Aug 12 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
What is the Cause? Erythematous Rash [Published MedPageToday.com - medical news plus CME for ph ... - Aug 04 2014]
(MedPage Today) -- An elderly patient with known T-cell lymphoma and splenomegaly develops a well demarcated erythematous lesion on her upper arm. A biopsy of the lesion demonstrates a neutrophilic infiltrate. ...
Weekly Roundup 7.4.14 [Published Eye on FDA - Jul 04 2014]
Happy Independence Day for America.  This week also so Canada Day.  So while a week where work productivity may have dipped, enjoyment factors probably drove up – at least in North America.  The season is marked by hot, humid days and stormy nights, ...
BioAlliance's lymphoma drug Beleodaq gets accel... [Published PBR - News - Jul 04 2014]
France-based BioAlliance Pharma has received topotarget accelerated approval from the US Food and Drug Administration (FDA) for Beleodaq to treat patients with relapsed or refractory peripheral T-cell lymphoma (R/R PTCL). ...
BioAlliance Pharma: FDA approval of Beleodaq™ (... [Published Business Wire Health News - Jul 03 2014]
PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Topotarget ...
Beleodaq Approved for Aggressive non-Hodgkin Ly... [Published Yahoo! Health News - Jul 03 2014]
THURSDAY, July 3, 2014 (HealthDay News) -- Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).... ...
1 2

Press Releases

sort by: Date | Relevance
Topotarget confirms receipt of acceptance-to-fi... [Published GlobeNewswire: Advertising News - Mar 26 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.